Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Beijing Boren Hospital
Welcome,
Profile
Billing
Logout
Products
Diseases
Products
Trials
News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
OVV-01
/ Joint Biosci, Beijing Boren Hospital
autologous anti-CD19 (human derived) chimeric antigen receptor T cells
/ Beijing Boren Hospital
Anti-CD22 CAR-T Cells
/ Beijing Boren Hospital
CI-135 CAR-T
/ Beijing Boren Hospital
autologous CD7-CAR T cells
/ Beijing Boren Hospital
sequential different B cell antigen-targeted CAR T-cell therapy
/ Beijing Boren Hospital
CAR-NK-CD19 cells
/ Beijing Boren Hospital
CD19/CD22 dual target CAR T
/ Beijing Boren Hospital
CD33 CAR T cells
/ Beijing Boren Hospital
CD5 CAR T
(CT125B) / Beijing Boren Hospital
CS-1-CART
/ Beijing Boren Hospital
Dual CD33/CLL1 CAR T
/ Sichuan Kelun Pharma, Beijing Boren Hospital
murine autologous anti-CD19 CART cells
/ Beijing Boren Hospital
